Clinical trial
Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That…
NCT00466505 · Vanderbilt-Ingram Cancer Center, Other · Completed
Key facts
| NCT number | NCT00466505 |
|---|---|
| Title | Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery |
| Official title | A Phase 2 Study of Cetuximab in Combination With Celecoxib in Colorectal Cancer |
| Lead sponsor | Vanderbilt-Ingram Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Biological, Drug, Genetic, Other |
| Interventions | cetuximab, celecoxib, proteomic profiling, immunohistochemistry staining method, laboratory biomarker analysis, mass spectrometry |
| Enrollment | 17 |
| Start date | May 1, 2005 |
| Primary completion | Jul 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Apr 27, 2007 |
| Last update posted | Dec 19, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: